Crystal Structure Insights for Alectinib Intermediate
Delving into the intricate details of alectinib intermediate's crystal structure and synthesis pathways.
Get a Quote & SampleProduct Core Value
![6-Cyano-2-[1-(4-ethyl-3-iodophenyl)-1-Methylethyl]-1H-Indole-3-Carboxylic Acid 1,1-Dimethylethyl Est](https://www.nbinno.com/webimg/gemini_6880d3c505a5c_1753273285.png)
6-Cyano-2-[1-(4-ethyl-3-iodophenyl)-1-Methylethyl]-1H-Indole-3-Carboxylic Acid 1,1-Dimethylethyl Ester
This advanced pharmaceutical intermediate is critical for the synthesis of alectinib, a targeted therapy for non-small cell lung cancer. Its precise molecular structure and optimized synthesis are key to producing high-quality active pharmaceutical ingredients (APIs).
- Understanding the alectinib intermediate crystal structure provides crucial data for quality control and process optimization in pharmaceutical manufacturing.
- Exploring advanced alectinib synthesis optimization is vital for reducing costs and improving the efficiency of drug production.
- Pharmaceutical intermediate characterization using techniques like X-ray diffraction ensures product purity and efficacy for downstream applications.
- The application of density functional theory in drug discovery aids in predicting molecular behavior and refining synthesis routes for complex compounds.
Key Advantages
Structural Precision
The detailed analysis of the alectinib intermediate crystal structure, including its packing and hydrogen bonding, ensures precise molecular configurations essential for drug efficacy.
Synthesis Efficiency
Optimized alectinib synthesis pathways lead to higher yields and reduced production costs, making the drug more accessible and commercially viable. This focus on alectinib synthesis optimization is paramount.
Quality Assurance
Rigorous pharmaceutical intermediate characterization methods guarantee the purity and consistency of the material, directly impacting the safety and effectiveness of the final pharmaceutical product.
Key Applications
Pharmaceutical Synthesis
Serves as a vital building block in the multi-step synthesis of alectinib, a potent anti-cancer medication, crucial for understanding alectinib synthesis optimization.
Drug Discovery Research
The study of its crystal structure contributes to broader knowledge in drug discovery and development, underscoring the importance of density functional theory in drug discovery.
Materials Science
Provides data for materials characterization and understanding solid-state properties of complex organic molecules, aiding in pharmaceutical intermediate characterization.
Quality Control
Essential for establishing robust quality control protocols in the pharmaceutical industry, emphasizing the need for accurate alectinib intermediate crystal structure data.